tDCS Combined With Constraint-Induced Therapy in Post-Stroke Upper Limb Rehabilitation
tDCS-CIT Strok
Effects of Transcranial Direct Current Stimulation Combined With Constraint-Induced Therapy on Upper Limb Motor Function in Individuals After Stroke: A Randomized Controlled Trial
1 other identifier
interventional
40
1 country
1
Brief Summary
The objective of this clinical trial is to evaluate the effects of transcranial direct current stimulation (tDCS) combined with constraint-induced therapy (CIT) on upper limb motor recovery in individuals after stroke. The main questions it aims to answer are: Does the combination of tDCS and CIT improve upper limb motor function compared to CIT alone? Does the combined intervention promote changes in muscle morphology and electromyographic activity? Researchers will compare the group receiving tDCS combined with constraint-induced therapy to the group receiving constraint-induced therapy alone to determine whether the addition of cortical neuromodulation enhances motor recovery outcomes. This is a randomized, controlled, and blinded clinical trial in which participants will be divided into two groups: one group will receive tDCS combined with CIMT, and the other will undergo only CIMT. The protocol will include 18 sessions over six weeks, three times a week. Clinical and instrumental assessments will be performed before, during, and after the intervention, including the Fugl-Meyer scale for the upper limb, musculoskeletal ultrasound for morphological analysis, and surface electromyography for muscle activity assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedStudy Start
First participant enrolled
April 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 10, 2027
March 9, 2026
March 1, 2026
8 months
March 3, 2026
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in upper limb motor function
Change in motor function measured by the Fugl-Meyer Assessment - Upper Extremity (FMA-UE) score
Baseline and 15 days after completion of the 18-session intervention protocol.
Study Arms (2)
Transcranial direct current stimulation + Constraint-induced movement therapy
EXPERIMENTALConstraint-induced movement therapy
ACTIVE COMPARATORInterventions
For tDCS application, the Microestim tDCS model stimulator (NKL Electronic Products Ltd., Brazil) will be used, with a pair of 5 cm x 7 cm (35 cm2) sponge electrodes, which will be soaked in saline solution providing a current density of 0.04 mA/cm2 that will be within safety limits (Russo et al 2017). Regarding electrode placement, the anodic electrode will be fixed over the primary motor cortex (M1) of the affected hemisphere, corresponding to point C3 or C4, according to the international 10-20 electroencephalography system. The cathodic electrode will be positioned over the primary motor cortex of the unaffected hemisphere, at point C4 or C3, respectively, according to the same system. This choice was based on a study by Sun Ho et al (2021) that studied the effects of tDCS and ICT to improve upper limb function after stroke. Volunteers in the a-ETCC group will undergo anodal stimulation at M1 with constant direct current at an intensity of 2 mA, for 20 minutes per session.
At the time of applying CIMT, a sling will be used positioned on the healthy upper limb (UL), then the affected or paretic UL will be stimulated to perform tasks involving activities of daily living and/or everyday life, with the volunteers seated, in an ergonomic way and with the material used for the activities positioned on a table. The healthy UL will be restrained by the sling, while the paretic UL will perform the activities. The CIMT protocol will involve three main components: repetitive task-oriented training of the affected upper limb; the transfer package, developed to facilitate the generalization of therapeutic gains obtained in the clinical setting to the participant's daily activities; and the restriction of the unaffected upper limb, with the aim of inducing functional use of the affected limb, as described in the classic study by Taub et al. (2006). It is worth noting that the restraint of the unaffected limb will occur exclusively during the intervention period
Eligibility Criteria
You may qualify if:
- (1) present a clinical diagnosis of stroke confirmed by imaging examination and/or report issued by a neurologist; (2) are in the chronic phase of the lesion with an occurrence time greater than six months; (3) hemiparesis with brachial predominance, mild to moderate motor deficit in the affected upper limb defined by a score between 19 and 55 points on the FMA-UE; (4) have minimum joint integrity to perform the movements required in the protocol with an active range of motion of at least 20° of wrist extension, 10° of extension of the metacarpophalangeal and interphalangeal joints and 20° of elbow extension considering the standard position of 90° elbow flexion, measured with a Carci® goniometer; (5) demonstrate the ability to understand and follow simple commands on the Mini Mental State Examination (MMSE) (ANNEX II) with a score higher than 23 points for literate persons and lower than 15 points for illiterate persons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
State University of Pará - Center for Biological and Health Sciences (UEPA)
Belém, Pará, 66087-662, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc Student - Principal Investigator
Study Record Dates
First Submitted
March 3, 2026
First Posted
March 9, 2026
Study Start
April 15, 2026
Primary Completion (Estimated)
December 15, 2026
Study Completion (Estimated)
April 10, 2027
Last Updated
March 9, 2026
Record last verified: 2026-03